PE-22-28 10mg 

Scientific Research Information

PE-22-28 10mg is a peptide product reference associated with preclinical scientific research into the TREK-1 potassium channel. The name supplied for this listing identifies the compound and a stated quantity of 10mg; however, the manufacturer, brand, formulation, packaging, purity, and batch documentation have not been provided. This page therefore separates published scientific background from product specifications that still require verification.

Product Overview

PE-22-28 is a short synthetic peptide described in scientific literature as an analogue of spadin. Researchers have investigated its interaction with TREK-1, a two-pore-domain potassium channel involved in cellular electrical signalling. A peer-reviewed study published in 2017 examined PE-22-28 in laboratory cell experiments and animal models. These findings represent preclinical research, not proof of safety or effectiveness in humans.

PubMed

The 10mg designation is the stated quantity for this product listing. It should not be interpreted as confirmation of the amount of verified peptide in a container, the formulation, or the concentration of any prepared solution. Those details should be confirmed against the actual label and supplier documentation before publication.

Why Evaluate PE-22-28 10mg?

For a research product, useful purchasing information begins with clear identification and verifiable documentation rather than broad promises about results.

Before publishing this listing, confirm the following details where applicable:

• Product identity: the label should identify PE-22-28 consistently.

• Stated quantity: confirm that the supplied pack is labelled as 10mg.

• Product format: specify the actual format only after checking the physical product and its documentation.

• Manufacturer or supplier: provide the correct name and traceable contact information.

• Batch documentation: state whether batch-specific documentation is available and make it accessible when appropriate.

• Packaging: describe the actual container and any included materials accurately.

• Research-use designation: ensure the wording reflects the product’s intended and lawful supply status.

These checks help customers distinguish documented product information from assumptions. No manufacturer, purity percentage, independent laboratory test, certificate of analysis, or certification has been supplied for this listing, so none is claimed here.

Research Information: What Is PE-22-28?

PE-22-28 has been studied as a shortened analogue of spadin. The 2017 publication investigated its interaction with TREK-1 using human TREK-1 channels expressed in laboratory cells, alongside experiments involving mice. The researchers reported effects in those experimental systems, including changes in behavioural tests and markers associated with neuronal research. These findings cannot establish that PE-22-28 produces equivalent effects in people.

PubMed

Researchers exploring this subject can consult the published PE-22-28 literature on PubMed, which provides a starting point for reviewing the available scientific record. Study design, experimental conditions, limitations, and independent replication should all be considered when evaluating findings.

It is important to distinguish a compound’s proposed research mechanism from an established medical use. Preclinical findings alone do not demonstrate clinical benefit, establish an appropriate human-use protocol, or confirm a product’s safety.

Quality, Documentation and Transparency

Reliable product information should be supported by evidence. If documentation is available for PE-22-28 10mg, the product page should identify what it covers and whether it relates to the exact batch supplied. A Certificate of Analysis, where provided, should be checked for the product identity, batch or lot number, test methods, reported results, and issuing laboratory.

Do not describe this product as independently tested, laboratory verified, GMP certified, pharmaceutical grade, or of a particular purity unless valid documentation supports the specific claim. At present, those details have not been established from the information supplied for this listing.

Before publication, confirm the seller’s contact details, returns policy, checkout security information, and applicable delivery terms. Only advertise UK stock, dispatch times, tracking, or delivery guarantees when these are accurate and can be substantiated.

Buying with Confidence in the UK

Customers should be able to understand what a product is, what documentation accompanies it, and what its stated intended use means. Clear labelling and transparent specifications are more useful than unsupported performance claims.

The UK regulatory position also matters. The MHRA’s guidance on supplying unlicensed medicinal products explains the regulatory framework for relevant unlicensed medicines. A “research use only” label does not, by itself, establish that a product can lawfully be marketed or supplied in the UK. Confirm the applicable classification and legal requirements before making the product available for sale.

Important Research-Use Notice

PE-22-28 is discussed in the cited literature as an experimental research compound. This page does not present it as an approved medicine or recommend it for diagnosing, treating, curing, or preventing any condition. Its product-specific quality, safety, regulatory status, and documentation remain unverified. Do not use this listing as medical advice or as instructions for human administration.